Literature DB >> 20729000

Arginine Vasopressin selectively enhances recognition of sexual cues in male humans.

Adam J Guastella1, Amanda R Kenyon, Christian Unkelbach, Gail A Alvares, Ian B Hickie.   

Abstract

Arginine Vasopressin modulates complex social and sexual behavior by enhancing social recognition, pair bonding, and aggression in non-human mammals. The influence of Arginine Vasopressin in human social and sexual behavior is, however, yet to be fully understood. We evaluated whether Arginine Vasopressin nasal spray facilitated recognition of positive and negative social and sexual stimuli over non-social stimuli. We used a recognition task that has already been shown to be sensitive to the influence of Oxytocin nasal spray (Unkelbach et al., 2008). In a double-blind, randomized, placebo-controlled, between-subjects design, 41 healthy male volunteers were administered Arginine Vasopressin (20 IU) or a placebo nasal spray after a 45 min wait period and then completed the recognition task. Results showed that the participants administered Arginine Vasopressin nasal spray were faster to detect sexual words over other types of words. This effect appeared for both positively and negatively valenced words. Results demonstrate for the first time that Arginine Vasopressin selectively enhances human cognition for sexual stimuli, regardless of valence. They further extend animal and human genetic studies linking Arginine Vasopressin to sexual behavior in males. Findings suggest an important cognitive mechanism that could enhance sexual behaviors in humans. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729000     DOI: 10.1016/j.psyneuen.2010.07.023

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  20 in total

Review 1.  Oxytocin and social motivation.

Authors:  Ilanit Gordon; Carina Martin; Ruth Feldman; James F Leckman
Journal:  Dev Cogn Neurosci       Date:  2011-10       Impact factor: 6.464

Review 2.  New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition.

Authors:  Elizabeth C Finger
Journal:  J Mol Neurosci       Date:  2011-05-27       Impact factor: 3.444

Review 3.  The animal and human neuroendocrinology of social cognition, motivation and behavior.

Authors:  Cade McCall; Tania Singer
Journal:  Nat Neurosci       Date:  2012-04-15       Impact factor: 24.884

Review 4.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.

Authors:  Andreas Meyer-Lindenberg; Gregor Domes; Peter Kirsch; Markus Heinrichs
Journal:  Nat Rev Neurosci       Date:  2011-08-19       Impact factor: 34.870

5.  Intranasal oxytocin, but not vasopressin, augments neural responses to toddlers in human fathers.

Authors:  Ting Li; Xu Chen; Jennifer Mascaro; Ebrahim Haroon; James K Rilling
Journal:  Horm Behav       Date:  2017-02-01       Impact factor: 3.587

Review 6.  Primate paternal care: Interactions between biology and social experience.

Authors:  Anne E Storey; Toni E Ziegler
Journal:  Horm Behav       Date:  2015-08-04       Impact factor: 3.587

7.  Posttraumatic stress disorder and partner-specific social cognition: a pilot study of sex differences in the impact of arginine vasopressin.

Authors:  Amy D Marshall
Journal:  Biol Psychol       Date:  2013-03-05       Impact factor: 3.251

Review 8.  Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior.

Authors:  Kelly M Dumais; Alexa H Veenema
Journal:  Front Neuroendocrinol       Date:  2015-05-04       Impact factor: 8.606

9.  A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Authors:  Karen J Parker; Ozge Oztan; Robin A Libove; Noreen Mohsin; Debra S Karhson; Raena D Sumiyoshi; Jacqueline E Summers; Kyle E Hinman; Kara S Motonaga; Jennifer M Phillips; Dean S Carson; Lawrence K Fung; Joseph P Garner; Antonio Y Hardan
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

Review 10.  The promiscuity of the oxytocin-vasopressin systems and their involvement in autism spectrum disorder.

Authors:  Amelie M Borie; Constantina Theofanopoulou; Elissar Andari
Journal:  Handb Clin Neurol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.